Danaparoid Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Danaparoid Side Effects
Did You Have Danaparoid Side Effect? |
Danaparoid Side Effects Poll Results |
|
Vote Below:
|
|
Danaparoid Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Danaparoid:
What is Your Question? Ask Community:
Daily Health Videos
Danaparoid Side Effects reported on Patientsville.com
None reported at this time.Danaparoid Side Effects reported to FDA
Showing 1-50 of 234 Next >
Danaparoid Side Effects Report #5202120-0Consumer or non-health professional from FRANCE reported Danaparoid side effect on Dec 20, 2006. Male patient, 54 years of age, was diagnosed with thrombosis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: amputation revision, anti-platelet antibody positive, joint dislocation, leg amputation, necrosis ischaemic, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, ENOXAPARIN. Patient recovered.
Danaparoid Side Effects Report #5214605-1
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on Jan 05, 2007. Male patient, 49 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: pericardial disease, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with APROTININ, HEPARIN. Patient recovered.
Danaparoid Side Effects Report #5215718-0
Consumer or non-health professional from AUSTRIA reported Danaparoid side effect on Dec 27, 2006. Female patient, 27 years of age, was diagnosed with thrombosis prophylaxis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abortion
, pregnancy . Danaparoid dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.Danaparoid Side Effects Report #5228777-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2007. Male patient, 67 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, haematuria, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with OFLOXACIN, OMEPRAZOLE, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5233963-5
Consumer or non-health professional from FRANCE reported Danaparoid side effect on Jan 22, 2007. Female patient, 36 years of age, was diagnosed with cardiopulmonary bypass and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiopulmonary bypass, procedural complication, thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.
Danaparoid Side Effects Report #5263382-7
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2007. Female patient, 57 years of age, was diagnosed with thrombosis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: thrombocytopenia, thrombosis, vascular procedure complication. Danaparoid dosage: unknown. During the same period patient was treated with FLUINDIONE. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5275224-4
Consumer or non-health professional from FRANCE reported Danaparoid side effect on Mar 08, 2007. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, disease recurrence, heparin-induced thrombocytopenia, pulmonary embolism . Danaparoid dosage: unknown. During the same period patient was treated with TRIMEBUTINE MALEATE, ACETAMINOPHEN, MORPHINE SULPHATE, MACROGOL, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.Danaparoid Side Effects Report #5314613-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Apr 22, 2004. Male patient, 64 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal pain
, adrenal insufficiency, circulatory collapse, confusional state, haemorrhage, heparin-induced thrombocytopenia, necrosis, pyrexia, urine sodium increased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.Danaparoid Side Effects Report #5329691-8
Consumer or non-health professional from FRANCE reported Danaparoid side effect on May 10, 2007. Male patient, 58 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. Patient died.
Danaparoid Side Effects Report #5047255-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiac tamponade, condition aggravated, infection
, leukaemia, liver disorder, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, AMIKACIN SULPHATE, PIPERACILLIN, IDARUBICIN, CYTARABINE, MEROPENEM, TOBRAMYCIN, ANTITHROMBIN III. Patient died.Danaparoid Side Effects Report #5047256-2
Consumer or non-health professional from JAPAN reported Danaparoid side effect on June 22, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, condition aggravated, fibrin d dimer increased, haemorrhage, pelvic fluid collection, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, TIENAM. Patient recovered.
Danaparoid Side Effects Report #5047257-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 26, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, loss of consciousness. Danaparoid dosage: unknown. During the same period patient was treated with DIAZEPAM, DEXAMETHASONE, FAMOTIDINE, MIDAZOLAM HYDROCHLORIDE, CYTARABINE, CEFTAZIDIME, RAMOSETRON HYDROCHLORIDE. Patient was hospitalized. Patient died.
Danaparoid Side Effects Report #5049291-7
Health Professional from AUSTRALIA reported Danaparoid side effect on June 29, 2006. Male patient was diagnosed with thrombectomy and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: platelet count decreased, vena cava thrombosis. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.
Danaparoid Side Effects Report #5050408-9
Danaparoid side effect was reported by a Consumer or non-health professional from CANADA on June 26, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: pulmonary embolism
, respiratory gas exchange disorder, thrombocytopenia. Danaparoid dosage: unknown. Patient recovered.Danaparoid Side Effects Report #5050457-0
Consumer or non-health professional from JAPAN reported Danaparoid side effect on May 31, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.
Danaparoid Side Effects Report #5051297-9
Danaparoid side effect was reported by a Health Professional from JAPAN on July 04, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemoglobin decreased, haemorrhage, haemorrhagic diathesis, henoch-schonlein purpura, renal disorder, staphylococcal infection
. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, WARFARIN. Patient was hospitalized. Patient recovered.Danaparoid Side Effects Report #5051298-0
Consumer or non-health professional from JAPAN reported Danaparoid side effect on July 03, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: depressed level of consciousness, haemorrhagic diathesis, pancytopenia, subarachnoid haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, MEROPENEM, FLUCONAZOLE, IMMUNE GLOBULIN INTRAVENOUS, NEUPOGEN, METHYLPREDNISOLONE SUCCINATE, TOBRAMYCIN, NAFAMOSTAT MESILATE. Patient died.
Danaparoid Side Effects Report #5051299-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gallbladder disorder, haemoglobin decreased, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.
Danaparoid Side Effects Report #5053983-3
Consumer or non-health professional from FRANCE reported Danaparoid side effect on July 06, 2006. Male patient, 61 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemodialysis, haemodynamic instability, heparin-induced thrombocytopenia, renal failure acute, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN CALCIUM, AVULAR, RAMIPRIL, FUROSEMIDE, POLYSTYRENE SULFONATE, INSULIN, ACENOCOUMAROL. Patient was hospitalized. Patient died.
Danaparoid Side Effects Report #5056233-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, neoplasm malignant. Danaparoid dosage: unknown. During the same period patient was treated with ULINASTATIN, SIVELESTAT, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, FLOMEX, FAMOTIDINE, PROPOFOL. Patient died.
Danaparoid Side Effects Report #5056234-9
Consumer or non-health professional from JAPAN reported Danaparoid side effect on July 07, 2006. Male patient, 43 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, bacteraemia, diarrhoea, enterocolitis, febrile neutropenia, fibrin degradation products increased, platelet count decreased, prothrombin time prolonged, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, TRANEXAMIC ACID, ETOPOSIDE, NOVANTRONE, ISEPAMICIN SULPHATE, CEFTAZIDIME, ALLOPURINOL. Patient recovered.
Danaparoid Side Effects Report #5056237-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia, malnutrition. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.
Danaparoid Side Effects Report #5056239-8
Consumer or non-health professional from JAPAN reported Danaparoid side effect on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.
Danaparoid Side Effects Report #5059430-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 12, 2006. Female patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: cardiac tamponade, dyspnoea, hyperhidrosis, malaise, pericardial haemorrhage, pleural effusion. Danaparoid dosage: unknown. During the same period patient was treated with GLYCEOL, EDARAVONE, CEFPIROME SULPHATE. Patient died.
Danaparoid Side Effects Report #5061700-6
Consumer or non-health professional from JAPAN reported Danaparoid side effect on July 10, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.
Danaparoid Side Effects Report #5062421-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, haemorrhage, renal failure, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.
Danaparoid Side Effects Report #5062425-3
Consumer or non-health professional from JAPAN reported Danaparoid side effect on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.
Danaparoid Side Effects Report #5062431-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, fibrin d dimer increased. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, DAUNOMYCIN, CYTARABINE, ANTITHROMBIN III, MINOPHAGEN C, CEFTAZIDIME. Patient recovered.
Danaparoid Side Effects Report #5063639-9
Physician from JAPAN reported Danaparoid side effect on July 18, 2006. Female patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage, myelodysplastic syndrome. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ACLARUBICIN HYDROCHLORIDE, CYTARABINE, GRANISETRON, GABEXATE MESILATE, CEFEPIME HYDROCHLORIDE, AMIKACIN SULPHATE, CARBENIN. Patient died.
Danaparoid Side Effects Report #5063640-5
Danaparoid side effect was reported by a Physician from JAPAN on July 06, 2006. Male patient, 56 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood urea increased, condition aggravated, haemoglobin decreased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, ANTITHROMBIN III, FAMOTIDINE. Patient died.
Danaparoid Side Effects Report #5063665-X
Consumer or non-health professional from FRANCE reported Danaparoid side effect on July 18, 2006. Male patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, melaena, purulent discharge, respiratory disorder. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.
Danaparoid Side Effects Report #5065826-2
Danaparoid side effect was reported by a Health Professional from FRANCE on July 19, 2006. Female patient, 83 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, hepatic failure, sepsis
, small intestine gangrene. Danaparoid dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, PANTOPRAZOLE, FUROSEMIDE. Patient died.Danaparoid Side Effects Report #5066924-X
Consumer or non-health professional from FRANCE reported Danaparoid side effect on July 18, 2006. Female patient, 84 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haematoma, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with AMOXICILLIN, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5076374-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 27, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.
Danaparoid Side Effects Report #5077936-4
Consumer or non-health professional from JAPAN reported Danaparoid side effect on Aug 02, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, haemoglobin decreased, platelet count increased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.
Danaparoid Side Effects Report #5083999-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.
Danaparoid Side Effects Report #5084705-8
Consumer or non-health professional from JAPAN reported Danaparoid side effect on Aug 03, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5084714-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2006. Male patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cerebral haemorrhage, sepsis
. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFTAZIDIME, AMIKACIN SULPHATE, FLURBIPROFEN AXETIL, GLYCEOL, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, IMMUNE GLOBULIN INTRAVENOUS. Patient died.Danaparoid Side Effects Report #5086058-8
Consumer or non-health professional from JAPAN reported Danaparoid side effect on Aug 11, 2006. Female patient, 93 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PIPERACILLIN, AZTREONAM, ANTITHROMBIN III. Patient died.
Danaparoid Side Effects Report #5093079-8
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Female patient, 77 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, immunology test abnormal. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN CALCIUM. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5093082-8
Consumer or non-health professional from JAPAN reported Danaparoid side effect on Aug 11, 2006. Female patient, 79 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: multi-organ failure, shock haemorrhagic. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, MEROPENEM TRIHYDRATE, CLINDAMYCIN PHOSPHATE, VANCOMYCIN HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS, FAMOTIDINE, CARPERITIDE. Patient died.
Danaparoid Side Effects Report #5093416-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 22, 2006. Female patient, 78 years of age, was diagnosed with phlebitis deep, thrombophlebitis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5093418-8
Consumer or non-health professional from FRANCE reported Danaparoid side effect on Aug 16, 2006. Female patient, 86 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal haematoma, pancytopenia, platelet count increased. Danaparoid dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PAROXETINE HYDROCHLORIDE, FOLIC ACID, FERROUS SULPHATE, BUFLOMEDIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5096633-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dehydration, hyperkalaemia, hypocholesterolaemia, leukocytosis, liver disorder, renal failure, sepsis
. Danaparoid dosage: unknown. During the same period patient was treated with CEFOZOPRAN HYDROCHLORIDE, VANCOMYCIN, BIAPENEM, TEICOPLANIN, MICAFUNGIN, PREDNISOLONE ACETATE, PROPOFOL. Patient died.Danaparoid Side Effects Report #5097841-7
Consumer or non-health professional from CANADA reported Danaparoid side effect on Aug 29, 2006. Female patient, 78 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: heparin-induced thrombocytopenia, pulmonary embolism
, respiratory gas exchange disorder. Danaparoid dosage: unknown. Patient was hospitalized. Patient recovered.Danaparoid Side Effects Report #5097842-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 24, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatinine increased, pulmonary alveolar haemorrhage, renal impairment, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5102723-8
Consumer or non-health professional from JAPAN reported Danaparoid side effect on Aug 15, 2006. Male patient, 87 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PROPOFOL, DOPAMINE, METHYLPREDNISOLONE SUCCINATE, ANTITHROMBIN III, DOBUTAMINE, NOREPINEPHRINE BITARTRATE, MEROPENEM TRIHYDRATE, IMMUNE GLOBULIN INTRAVENOUS. Patient recovered.
Danaparoid Side Effects Report #5102731-7
Danaparoid side effect was reported by a Consumer or non-health professional from GERMANY on Aug 31, 2006. Female patient was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient died.
Danaparoid Side Effects Report #5104110-5
Consumer or non-health professional from FRANCE reported Danaparoid side effect on Aug 28, 2006. Male patient, 89 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, FUROSEMIDE, FERROUS FUMARATE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Danaparoid Side Effects Report #5108484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased, sepsis
. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.Showing 1-50 of 234 Next >